Status:
COMPLETED
Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease
Lead Sponsor:
Valentis
Conditions:
Peripheral Vascular Disease
Eligibility:
All Genders
40-78 years
Phase:
PHASE2
Brief Summary
This is a phase II, multicenter, randomized, double-blind, placebo-controlled trial in which subjects with intermittent claudication (IC) will be randomized to receive a single treatment of VLTS-934 (...
Detailed Description
This is a Phase II, multicenter, randomized, double-blind, placebo-controlled trial in which subjects with IC will be randomized to receive a single treatment of VLTS-934 (84 mL, or a total of 420 mg ...
Eligibility Criteria
Inclusion
- Diagnosis of peripheral arterial disease in both legs
- History of exercise limiting symptoms
Exclusion
- Lower limb revascularization surgery with 2 months of study entry
- Diagnosis of critical limb ischemia
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
July 1 2006
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT00113009
Start Date
March 1 2005
End Date
July 1 2006
Last Update
November 22 2007
Active Locations (32)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States
2
Beverly Hills, California, United States
3
Los Angeles, California, United States
4
Mountain View, California, United States